- Atrasentan
Drugbox
IUPAC_name = (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1- [2-(dibutylamino)-2-oxoethyl] -2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
CAS_number =
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 159594
DrugBank =
chemical_formula =
C=29 | H=38 | N=2 | O=6
molecular_weight = 510.621 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =routes_of_administration =
Atrasentan is a substance that is being studied in the treatment of
cancer . It belongs to the family of drugs calledendothelin-1 protein receptor antagonists .External links
* [http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=45029 Atrasentan] entry in the public domain NCI Dictionary of Cancer Terms
Wikimedia Foundation. 2010.